The critical role of clinical pharmacology in geriatric psychopharmacology (Q37335839)

19 August 2017

1 reference

title

The critical role of clinical pharmacology in geriatric psychopharmacology (English)

1 reference

19 August 2017

1 reference

Bg Pollock

1

1 reference

19 August 2017

Ce Forsyth

series ordinal

2

1 reference

19 August 2017

Rr Bies

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

26 November 2008

1 reference

Clinical Pharmacology & Therapeutics

19 August 2017

published in

1 reference

19 August 2017

volume

85

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

89-93

1 reference

Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

Relationship between diazepam dose, plasma level, age, and central nervous system depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

Course and outcomes of depression in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

1 reference

7 January 2021

Depression and Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Concept of disease in geriatric psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

High anxiety is associated with an increased risk of death in an older tri-ethnic population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Maintenance treatment of major depression in old age

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Psychotropic prescription use by community-dwelling elderly in the United States

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Exploring the variation in Ontario nursing home prescribing rates for antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Current use of psychotropic medication in nursing homes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Incidence and preventability of adverse drug events in nursing homes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Effect of selective serotonin reuptake inhibitors on the risk of fracture

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Expanding the black box - depression, antidepressants, and the risk of suicide

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Sex, race, and smoking impact olanzapine exposure.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Bioequivalence revisited: influence of age and sex on CYP enzymes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Paroxetine-induced hyponatremia in older adults: a 12-week prospective study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Pharmacogenetics of antidepressant medication intolerance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Anticholinergic activity of 107 medications commonly used by older adults

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Paroxetine: pharmacokinetic and antidepressant effect in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Steady-state pharmacokinetics of citalopram in young and elderly subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.229

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.229

1 reference

Dimensions Publication ID

19 August 2017

1007864744

0 references

1 reference